相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitis
Nicolas De Leiris et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps
Silvia Paola Caminiti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Harmonisation of PET/CT contrast recovery performance for brain studies
E. E. Verwer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis
Manon Bordonne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Deep learning-based T1-enhanced selection of linear attenuation coefficients (DL-TESLA) for PET/MR attenuation correction in dementia neuroimaging
Yasheng Chen et al.
MAGNETIC RESONANCE IN MEDICINE (2021)
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
Xianyuan Xiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses
Tejpal Gupta et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Finding our way through the labyrinth of dementia biomarkers
Gael Chetelat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Changes of Metabolic Connectivity in Dementia with Lewy Bodies with Visual Hallucinations: A 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Study
Giovanni Zorzi et al.
BRAIN CONNECTIVITY (2021)
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field
Antoine Verger et al.
ANNALS OF NEUROLOGY (2021)
Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction
Marie N. N. Hellem et al.
PLOS ONE (2021)
Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT
Joyce van Sluis et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
Paul L. de Zwart et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Brain metabolic signatures across the Alzheimer's disease spectrum
Arianna Sala et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease
Le Gjerum et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics
Donatienne Van Weehaeghe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Relationship between PET metabolism and SEEG epileptogenicity in focal lesional epilepsy
Stanislas Lagarde et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Longitudinal trajectories of Alzheimer's ATN biomarkers in elderly persons without dementia
Meng-Shan Tan et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective
Geert Jan Biessels et al.
LANCET NEUROLOGY (2020)
Diagnostic Yield of Extensive Systemic Staging Including Whole-body 18F-fluoro-deoxy-glucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis
Tejpal Gupta et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Performance characteristics of the digital uMI550 PET/CT system according to the NEMA NU2-2018 standard
Shuguang Chen et al.
EJNMMI PHYSICS (2020)
MR Image-Based Attenuation Correction of Brain PET Imaging: Review of Literature on Machine Learning Approaches for Segmentation
Imene Mecheter et al.
JOURNAL OF DIGITAL IMAGING (2020)
AI-driven attenuation correction for brain PET/MRI: Clinical evaluation of a dementia cohort and importance of the training group size
Claes Nohr Ladefoged et al.
NEUROIMAGE (2020)
Multicenter Validation of Metabolic Abnormalities Related toPSPAccording to theMDS-PSPCriteria
Gloria Marti-Andres et al.
MOVEMENT DISORDERS (2020)
Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging
Otto M. Henriksen et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Validation of PET/MRI attenuation correction methodology in the study of brain tumours
Francesca De Luca et al.
BMC MEDICAL IMAGING (2020)
Direct comparison of brain [18F]FDG images acquired by SiPM-based and PMT-based PET/CT: phantom and clinical studies
Kei Wagatsuma et al.
EJNMMI PHYSICS (2020)
A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment
Valentina Garibotto et al.
CURRENT ALZHEIMER RESEARCH (2020)
Intensity normalization methods in brain FDG-PET quantification
Francisco J. Lopez-Gonzalez et al.
NEUROIMAGE (2020)
High-quality brain perfusion SPECT images may be achieved with a high-speed recording using 360° CZT camera
Manon Bordonne et al.
EJNMMI PHYSICS (2020)
Functional brain connectome in posterior cortical atrophy
Raffaella Migliaccio et al.
NEUROIMAGE-CLINICAL (2020)
Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging
Benjamin L. Viglianti et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The predictive value of hypometabolism in focal epilepsy: a prospective study in surgical candidates
Jose Tomas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET
Leonardo Iaccarino et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders
Cecilia Peralta et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
Increase of precuneus metabolism correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: an 18F-FDG PET study during virtual reality exposure to war
P. F. Rousseau et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study
Ya-Nan Ou et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Head-to-head comparison of image quality between brain 18F-FDG images recorded with a fully digital versus a last-generation analog PET camera
Julien Salvadori et al.
EJNMMI RESEARCH (2019)
Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
Dominique Endres et al.
FRONTIERS IN NEUROLOGY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements
Mahsa Eskian et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Performance Evaluation of the Vereos PET/CT System According to the NEMA NU2-2012 Standard
Ivo Rausch et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Performance Characteristics of the Digital Biograph Vision PET/CT System
Joyce van Sluis et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults
Min Soo Byun et al.
NEUROIMAGE-CLINICAL (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
F. Nobili et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment
Ivayla Apostolova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia
Zuzana Walker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease
Federica Agosta et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
Peter J. Nestor et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
Flavio Nobili et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
Femke Bouwman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts
Jingjie Ge et al.
HUMAN BRAIN MAPPING (2018)
Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives
A. Verger et al.
REVUE NEUROLOGIQUE (2018)
Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain
Kristian N. Mortensen et al.
NEURAL PLASTICITY (2018)
Voxel-based comparison of brain glucose metabolism between patients with Cushing's disease and healthy subjects
Shuai Liu et al.
NEUROIMAGE-CLINICAL (2018)
18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
Ryan A. Townley et al.
NEUROIMAGE-CLINICAL (2018)
Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease
Nienke M. E. Scheltens et al.
NEUROIMAGE-CLINICAL (2018)
Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives
Daniele Mauro et al.
CURRENT MEDICINAL CHEMISTRY (2018)
The renaissance of functional 18F-FDG PET brain activation imaging
Antoine Verger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Brain metabolism and related connectivity in patients with acrophobia treated by virtual reality therapy: an F-18-FDG PET pilot study sensitized by virtual exposure
Antoine Verger et al.
EJNMMI RESEARCH (2018)
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies
Jennifer L. Whitwell et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Technical and instrumentational foundations of PET/MRI
Ivo Rausch et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System
David F. C. Hsu et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids
Alison H. Clifford et al.
JOURNAL OF RHEUMATOLOGY (2017)
Amyotrophic lateral sclerosis
Michael A. van Es et al.
LANCET (2017)
Radiological Biomarkers for Diagnosis in PSP: Where Are We and Where Do We Need to Be?
Jennifer L. Whitwell et al.
MOVEMENT DISORDERS (2017)
[18F]FDG PET signal is driven by astroglial glutamate transport
Eduardo R. Zimmer et al.
NATURE NEUROSCIENCE (2017)
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Valentina Garibotto et al.
NEUROBIOLOGY OF AGING (2017)
Data-driven identification of intensity normalization region based on longitudinal coherency of 18F-FDG metabolism in the healthy brain
Huiwei Zhang et al.
NEUROIMAGE (2017)
A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients
Claes N. Ladefoged et al.
NEUROIMAGE (2017)
RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants
Claes N. Ladefoged et al.
FRONTIERS IN NEUROSCIENCE (2017)
Partial volume correction for PET quantification and its impact on brain network in Alzheimer's disease
Jiarui Yang et al.
SCIENTIFIC REPORTS (2017)
Neuroimaging of deployment-associated traumatic brain injury (TBI) with a focus on mild TBI (mTBI) since 2009
David H. Salat et al.
BRAIN INJURY (2017)
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis
Marco Pagani et al.
HUMAN BRAIN MAPPING (2016)
Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis
Donatienne Van Weehaeghe et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18F-FDG
Andreas Hahn et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis
Silvia Morbelli et al.
LANCET NEUROLOGY (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia
Jennifer L. Whitwell et al.
BRAIN AND LANGUAGE (2015)
18FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value
Eric Guedj et al.
EPILEPSIA (2015)
Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
Tarun D. Singh et al.
JOURNAL OF NEUROLOGY (2015)
Alcohol Decreases Baseline Brain Glucose Metabolism More in Heavy Drinkers Than Controls But Has No Effect on Stimulation-Induced Metabolic Increases
Nora D. Volkow et al.
JOURNAL OF NEUROSCIENCE (2015)
Post-therapy normalization of brain FDG-PET in Morvan's syndrome
L. Benedetti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
Anna Caroli et al.
NEUROLOGY (2015)
Visual Versus Semi-Quantitative Analysis of F-18-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project
Silvia Morbelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A disease-specific metabolic brain network associated with corticobasal degeneration
Martin Niethammer et al.
BRAIN (2014)
Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines
Michael Lassmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease
Meike Herben-Dekker et al.
JOURNAL OF NEUROLOGY (2014)
Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
Richard K. J. Brown et al.
RADIOGRAPHICS (2014)
Value of 18Fluorodeoxyglucose-Positron-Emission Tomography in Amyotrophic Lateral Sclerosis A Prospective Study
Koen Van Laere et al.
JAMA NEUROLOGY (2014)
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Daniela Perani et al.
NEUROIMAGE-CLINICAL (2014)
Metabolic network as a progression biomarker of premanifest Huntington's disease
Chris C. Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types
Annette Baumgartner et al.
JOURNAL OF NEUROLOGY (2013)
EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
Francois Jamar et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Imaging markers for Alzheimer disease Which vs how
Giovanni B. Frisoni et al.
NEUROLOGY (2013)
The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy
Beril Gok et al.
NEURORADIOLOGY (2013)
Metabolic brain networks in translational neurology: Concepts and applications
Martin Niethammer et al.
ANNALS OF NEUROLOGY (2012)
Visual Assessment Versus Quantitative Three-Dimensional Stereotactic Surface Projection Fluorodeoxyglucose Positron Emission Tomography for Detection of Mild Cognitive Impairment and Alzheimer Disease
Vance T. Lehman et al.
CLINICAL NUCLEAR MEDICINE (2012)
Surgical outcome in PET-positive, MRI-negative patients with temporal lobe epilepsy
Carla LoPinto-Khoury et al.
EPILEPSIA (2012)
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size
Andrea Ciarmiello et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas
Cecile Colavolpe et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan
Cecile Colavolpe et al.
NEURO-ONCOLOGY (2012)
The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease
Benjamin A. Thomas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Routine quality control recommendations for nuclear medicine instrumentation
Ellinor Busemann Sokole et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization
R. C. Petersen et al.
NEUROLOGY (2010)
Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques
Matthias Hofmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
EANM procedure guidelines for PET brain imaging using [F-18]FDG, version 2
Andrea Varrone et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Hemisphere-specific Episodic Memory Networks in the Human Brain: A Correlation Study between Intracarotid Amobarbital Test and [18F]FDG-PET
Nozomi Akanuma et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2009)
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
Lisa Mosconi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Abnormal metabolic networks in atypical parkinsonism
Thomas Eckert et al.
MOVEMENT DISORDERS (2008)
Normalization in PET group comparison studies - The importance of a valid reference region
Per Borghammer et al.
NEUROIMAGE (2008)
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18
Igor Yakushev et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse
S. M. Berman et al.
MOLECULAR PSYCHIATRY (2008)
Thalamic metabolism and symptom onset in preclinical Huntington's disease
A. Feigin et al.
BRAIN (2007)
Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP
Atsushi K. Kono et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
The use of SPECT and PET in routine clinical practice in epilepsy
Wim Van Paesschen et al.
CURRENT OPINION IN NEUROLOGY (2007)
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy
Anita B. Vinton et al.
BRAIN (2007)
Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Ian McKeith et al.
LANCET NEUROLOGY (2007)
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP
K Ishii et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
FDG PET in the differential diagnosis of parkinsonian disorders
T Eckert et al.
NEUROIMAGE (2005)
The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies
TR Henry et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2004)
Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner
TH Wu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
K Herholz et al.
NEUROIMAGE (2002)
Verbal memory in left temporal lobe epilepsy: Evidence for task-related localization
DL Weintrob et al.
ANNALS OF NEUROLOGY (2002)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET
G Berding et al.
MOVEMENT DISORDERS (2001)
Localisation of motor areas in brain tumour patients:: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation
M Schreckenberger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy -: A study using positron emission tomography with 18fluorodeoxyglucose
S Dupont et al.
ARCHIVES OF NEUROLOGY (2000)
PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review
P Videbech
ACTA PSYCHIATRICA SCANDINAVICA (2000)
分享论文
